Expression and Clinical Pathological Significance of miR-200a in Concurrent Cholangiocarcinoma Associated with Hepatolithiasis

BACKGROUND: Approximately 2–10% of the patients with hepatolithiasis may develop cholangiocarcinoma (CCA). Despite recent advances in the treatment of cancers, the 5-year survival rate for CCA patients currently remains poor, primarily due to early local invasion and distant metastasis of the cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chen, Yang, Dinghua, Wang, Qunwei, Wang, Xintian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657761/
https://www.ncbi.nlm.nih.gov/pubmed/26586458
http://dx.doi.org/10.12659/MSM.895013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657761/
https://www.ncbi.nlm.nih.gov/pubmed/26586458
http://dx.doi.org/10.12659/MSM.895013

Ejemplares similares